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Background: Cerebrospinal fluid (CSF) lactate is a potential biomarker for bacterial meningitis in children. To this end,
we performed a single-center retrospective cohort study of children from Sao Paulo, Brazil, with CSF pleocytosis to
evaluate the ability of CSF lactate to distinguish between children with bacterial and aseptic meningitis. We determined
the optimum cutoff point for CSF lactate using receiver-operator curve (ROC) analysis.
Findings: We identified 451 children of whom 40 (9%) had bacterial meningitis. Children with bacterial meningitis had
a higher median CSF lactate level [9.6 mmol/l, interquartile range (IQR) 3.2-38.5 mmol/l bacterial meningitis vs.
2.0 mmol/l, IQR 1.2-2.8 mmol/l aseptic meningitis]. A CSF lactate cutoff point of 3.0 mmol/l had a sensitivity of 95%
[95% confidence interval (CI) 83-99%), specificity of 94% (95% CI 90-96%) and negative predictive value of 99.3%
(95% CI 97.7-99.9%) for bacterial meningitis.
Conclusions: In combination with a validated meningitis clinical prediction rule, the CSF lactate level can be used to
distinguish between bacterial and aseptic meningitis in children with CSF pleocytosis.
Keywords: Bacterial meningitis; Aseptic meningitis; Cerebrospinal fluid; LactateFindings
Introduction
While bacterial meningitis causes significant morbidity and
mortality despite advances in antibiotic therapy, aseptic
meningitis is typically a benign condition requiring only
supportive care [1]. Rapid differentiation between bacterial
and aseptic meningitis allows early initiation of appropriate
therapy for children at risk for having bacterial meningitis
without overtreating low-risk children. Although available
conjugate vaccinations against Streptococcus pneumoniae
and Neisseria meningitidis have decreased the bacterial
meningitis incidence, incomplete vaccine uptake as well as
infections caused by bacterial serogroups not included in
the vaccine makes bacterial meningitis a clinical concern in
children, especially in resource-poor settings [2].
The gold standard for the diagnosis for bacterial meningi-
tis is culture, which requires several days to return results
[3,4]. Rapidly available biomarkers such as cerebrospinal
(CSF) lactate have been studied to distinguish bacterial* Correspondence: emf2002@uol.com.br
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reproduction in any medium, provided the origfrom aseptic meningitis before the results of bacterial cul-
tures become available. CSF lactate levels are high in chil-
dren with bacterial meningitis as lactate is produced by
both bacterial anaerobic metabolism as well as ischemic
brain tissue [5]. The predictive ability of CSF lactate for
bacterial meningitis has been examined in two recently
published meta-analyses [6,7]. In our large retrospective co-
hort of children with meningitis, we sought to establish the
optimal CSF lactate cutoff point to accurately distinguish
between bacterial and aseptic meningitis [8].
Materials and methods
To this end, we performed a retrospective cohort study of
children with meningitis between 1 month and 15 years of
age who presented to a single emergency department (ED)
of the University Hospital over the 12-year period (2001–
2012). The study was approved by the institutional review
board. Details of the study protocol have been described
previously [8]. We included children who had clinical
findings consistent with meningitis (e.g., fever, headache,
vomiting or nausea, and neck stiffness) along with CSF
white blood cells (WBC) ≥10 cells/μl [corrected for the
presence of CSF red blood cells (RBC) using a standard
1:500 ratio of leukocytes to erythrocytes] and who hadr. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly credited.
Table 1 CSF lactate concentration in children with
bacterial and aseptic meningitis
Bacterial meningitis Aseptic meningitis
(n = 40) (n = 411)
Mean CSF lactate, mmol/l 22.1 2.8
(SD) (±14.1) ( ±2.2)
Median CSF lactate, mmol/l 9.6 2.0
(interquartile range) (3.2–38.5) (1.2–2.8)
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limited our study population to those children who had
CSF lactate obtained by the treating clinician. We ex-
cluded children with any of the following: critical illnesses,
any purpura, presence of a ventricular shunt or recent
neurosurgery, immunosuppression and other bacterial in-
fections requiring parenteral antibiotics. We also excluded
children who had received any antibiotic pretreatment
within 72 h of diagnostic lumbar puncture as pretreatment
can render cultures falsely negative.
We reviewed the medical records for all eligible children
and abstracted relevant clinical and laboratory factors for
all study patients. The CSF lactate level was measured by
the hospital clinical laboratory using standard enzymatic
methods (ADIVA Chemistry, Siemens, Bayswater Victoria,
Australia).
We defined a case of bacterial meningitis as a child with
either a positive CSF culture or CSF pleocytosis with a posi-
tive blood culture for a bacterial pathogen [9]. We defined
a case of aseptic meningitis as a child with meningitis who
had not received antibiotics prior to diagnostic lumbar
puncture who had a negative CSF bacterial culture [9].
For statistical analysis, we first selected a range of cutoff
points for the CSF lactate biomarker to distinguish bacter-
ial from aseptic meningitis. We reported the sensitivity,
specificity and negative predictive value (NPV) for bacter-
ial meningitis of each CSF lactate cutoff point. Next, we
generated a receiver-operator curve (ROC) to visually rep-
resent the trade-off between sensitivity and specificity. We
utilized ROC curve analysis to select the optimal CSF lac-
tate cutoff point to minimize both the number of false
positives (children with aseptic meningitis with CSF lac-
tate above the chosen cutoff point) as well as false nega-
tives (children with bacterial meningitis with CSF lactate
below the cutoff point). A Mann–Whitney U-test was per-
formed to compare lactate levels between children with
bacterial and aseptic meningitis. We used PASW Statistics
(version 21.0, Chicago, IL, 2012) for all statistical analyses.
Results
We identified 494 children with meningitis who met the
study criteria, of which 43 (9%) did not have a CSF lac-
tate analysis performed. Of the 451 study patients, the
mean age was 4.9 years [median 4.0 years;interquartile
range (IQR) 0.8-7.3 years], and 306 (68%) were male. Of
the 40 children with bacterial meningitis (9% of study
patients), the two most common bacterial pathogens were
Neisseria meningitidis (55% of bacterial meningitis cases)
and Streptococcus pneumoniae (33% of cases). Of the 22
children with Neisseria meningitidis meningitis, 8 had a
positive CSF culture alone, 9 had positive CSF and blood
cultures, and 5 had a positive blood culture with CSF pleo-
cytosis. Of the 13 children with Streptococcus pneumoniae
meningitis, 2 had a positive CSF culture alone, 3 hadpositive CSF and blood cultures, and 8 had a positive
blood culture with CSF pleocytosis. The remaining five
children with bacterial meningitis had a positive CSF
culture.
Children with bacterial meningitis had CSF lactate con-
centrations (Table 1). Each step-wise increase in the CSF
lactate cutoff point lowered the sensitivity, but increased
the specificity for bacterial meningitis (Table 2).
Next we present a ROC curve for CSF lactate for bacter-
ial meningitis (Figure 1). Using ROC analysis, we selected
an optimal cutoff point for CSF lactate of 3.0 mmol/l to
distinguish between bacterial and aseptic meningitis [area
under the curve 0.96; 95% confidence interval (CI) 0.93-
0.99]. CSF lactate ≥3.0 mmol/l had a sensitivity of 95.0%
(95% CI 83.1–99.4%), a specificity of 93.6% (95% CI 90.3-
96.0%) and NPV of 99.3% (95% CI 97.7-99.9%) for bacter-
ial meningitis.
Two children with bacterial meningitis had a CSF lactate
value < 3.0 mmol, but both had a positive CSF gram stain
as well as peripheral and CSF leukocytosis. One of these
children had Staphylococcus aureus meningitis and the
other Streptococcus pyogenes meningitis. Both children
were hospitalized and received broad-spectrum antibi-
otics, with good clinical outcomes.
Discussion
In our large retrospective cohort of children with men-
ingitis, CSF lactate ≥3.0 mmol/l accurately distinguished
between bacterial and aseptic meningitis. However, two
children (5% of children with bacterial meningitis) had
CSF lactate below the cutoff point. Therefore, CSF lac-
tate should not be used alone but rather combined with
a validated clinical prediction model such as the Bacter-
ial Meningitis Score [8-10]. Importantly, this prediction
model appropriately identified both children with bac-
terial meningitis and CSF lactate <3.0 mmol/l.
Two recent meta-analyses evaluated the ability of CSF
lactate to distinguish aseptic from bacterial meningitis
[6,7]. These two studies included 38 unique studies with
between 15 and 201 patients per study. Using a CSF lac-
tate cutoff point between 2.1 and 4.4 mmol/l, the aggre-
gated sensitivity of CSF lactate for bacterial meningitis
was 93% or 96% and specificity 94% or 96%, respectively.
Our findings were similar, but our study was larger than
Table 2 The diagnostic accuracy of CSF lactate for bacterial meningitis by cutoff point
CSF lactate
(mmol/l)
n = 451 Sensitivity Specificity Negative predictive value (NPV)
n (%) n (%) (95% CI) n (%) (95% CI) n% (95% CI)
≥1.0 mmol/l 442 (98) 100 (91.2-100) 2.8 (1.3-5.2) 100 (66.4-100)
≥1.5 mmol/l 388 (86) 100 (91.2-100) 25.2 (20.5-30.2) 100 (95.6-100)
≥2.0 mmol/l 246 (55) 97.5 (86.8-99.9) 55.2 (49.6-60.7) 99.4 (97.0-100)
≥2.5 mmol/l 102 (23) 95.0 (83.1-99.4) 85.6 (81.3-89.2) 99.3 (97.5-99.9)
≥3.0 mmol/l 56 (12) 95.0 (83.1-99.4) 93.6 (90.3-96.0) 99.3 (97.7-99.9)
≥3.5 mmol/l 47 (10) 90.0 (76.3-97.2) 96 (93.3-97.9) 98.7 (96.8-99.7)
≥4.0 mmol/l 34 (7.5) 82.5 (67.2-92.7) 96.3 (93.7-98.1) 97.8 (95.6-99.1)
≥4.5 mmol/l 30 (6.6) 72.5 (56.1-85.4) 96.6 (94.0-98.3) 96.6 (94.0-98.3)
≥5.0 mmol/l 26 (5.8) 72.5 (56.1-85.4) 97.5 (95.2-98.9) 96.2 (94.1-98.3)
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the only pediatric study conducted in an ED setting
where initial management decisions for children with
meningitis must occur.
The management of children with meningitis may differ
in resource-poor settings asthe incidence of bacterial
meningitis may be considerably higher and clinicians may
have limited access to diagnostic laboratories [11]. Available
hand-held testing platforms can provide point-of-care test-
ing for CSF lactate. In a small study conducted in Uganda,
CSF lactate analysis using a hand-held device had good sen-











Figure 1 Receiver-operating curve for CSF lactate to distinguish bactelikely multi-centered, studies are needed to further evaluate
the diagnostic accuracy of CSF lactate in resource-poor
settings.
Our study has several limitations. First our study was
retrospective, and we could not assess general appearance
of the children. Children who appear unwell at presentation
require inpatient therapy regardless of the risk of bacterial
meningitis. Second, not all children with aseptic meningitis
had a specific infectious etiology identified. However, we re-
liably excluded bacterial meningitis in these children as all
had a CSF bacterial culture with no antibiotic pretreatment
within 72 h of diagnostic LP. Third, not all children had Positive Rate
rial from aseptic meningitis.
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study. In fact, the proportion of children who had CSF
lactate increased over the study time period. However,
the clinical and laboratory presentations of children
who did and did not have CSF lactate obtained were
similar (data not shown). Last, we had a relatively small
number of children with bacterial meningitis, which
limited our ability to measure the diagnostic accuracy of
CSF lactate. We were also unable to compare CSF lac-
tate by bacterial meningitis pathogen.
The findings of this study suggest that CSF lactate
is a reliable biomarker to distinguish between bacterial
meningitis from aseptic meningitis, albeit with imper-
fect sensitivity. In combination with other validated
clinical prediction models, CSF lactate can assist with
clinical decision-making for children with meningitis.
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